Moon walk prep: scientists study how unloading rewires the brain

NCT ID NCT07607340

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how 14 days of simulated microgravity (using a leg suspension model) changes the brain's movement programs and muscle control. Twenty-four healthy adults will have one leg unloaded while using crutches, then walk on a treadmill in lunar gravity during a parabolic flight. The goal is to understand how the brain and muscles adapt to disuse and reactivate under partial gravity, which could help astronauts and people recovering from limb immobilization.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could improve astronaut training and rehabilitation for people with limb immobilization.
What could go wrong
This is a small, early-stage observational study with only 24 healthy participants, so results may not apply to broader populations or real spaceflight conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- 18-60 years of age, willing to participate Exclusion Criteria: * high activity level according to the GLTEQ * contraindications to exercise * pregnancy * contraindications to MRI * active cardiovascular disease * cerebrovascular disease including previous stroke * aneurysm (large vessels or intracranial) * pulmonary disease including pulmonary hypertension or COPD * metabolic diseases (including: hyper/hypoparathyroidism, hyper/hypothyroidism, Cushing's disease, type 1 or type 2 diabetes) * active inflammatory bowel disease * kidney disease * malignancy * recent steroid treatment (within the past 6 months), or hormone replacement therapy * coagulation disorders * musculoskeletal or neurological diseases * diseases requiring long-term medication, including statin therapy * smoking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Unilateral lower limb suspension (simulated microgravity) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Karolinska Institutet

    RECRUITING

    Huddinge, Stockholm County, 14152, Sweden